FDA data Registry peer set 1 peer

Alternatives to aprepitant

1 same-class SPL records vs aprepitant - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

Brand: Emend

NK1 Receptor Antagonist (Antiemetic) Prescription 1 alternative found

About aprepitant

Aprepitant (Emend) is a medicine that helps prevent nausea and vomiting. It belongs to a class of drugs called NK1 receptor antagonists.

Used for: Aprepitant is used to prevent nausea and vomiting caused by chemotherapy. It can be used for both strong and moderate chemotherapy treatments. It is also used to prevent nausea and vomiting after surgery in adults.

1 NK1 Receptor Antagonist (Antiemetic) peers (wide set)

Compare aprepitant vs rolapitant side-by-side →

aprepitant vs rolapitant · FAERS reaction fields

FAERS top-reaction field "Nausea" shows the widest count spread between aprepitant and rolapitant in this extract (2,066-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect aprepitant rolapitant
Nausea 2,145 79
Fatigue 1,769 50
Pyrexia 1,589 -
Diarrhoea 1,542 29
Dyspnoea 1,508 34
Vomiting 1,474 22
Alopecia 1,274 -
Rash 1,210 -

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

aprepitant peer mix vs class inventory

Peer mix

0 OTC and 1 Rx SPL records in this peer set (1 total). Class inventory for NK1 Receptor Antagonist (Antiemetic): 2 drugs.

Frequently Asked Questions

What same-class SPL records sit beside aprepitant?
This registry lists 1 NK1 Receptor Antagonist (Antiemetic) medication records beside aprepitant, including rolapitant. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide NK1 Receptor Antagonist (Antiemetic) peer set (1 records)

aprepitant (Emend) sits in a wide NK1 Receptor Antagonist (Antiemetic) peer set (1 of 1 class peers shown). Labeled indication field for aprepitant: Aprepitant is used to prevent nausea and vomiting caused by chemotherapy.

Top FAERS reaction fields for aprepitant total 14,687 reports across 10 reactions, set beside rolapitant. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full aprepitant profile →

Field note for aprepitant: see also the generic vs brand label guide when reading Emend SPL strings.